We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ARAB HEALTH - INFORMA

Download Mobile App




Minimally Invasive Coronary Artery Bypass Method Offers Safer Alternative to Open-Heart Surgery

By HospiMedica International staff writers
Posted on 15 Jan 2026

Coronary artery obstruction is a rare but often fatal complication of heart-valve replacement, particularly in patients with complex anatomy or prior cardiac interventions. More...

In such cases, traditional open-heart bypass surgery may be too risky or not possible at all. Existing minimally invasive options also fail when the coronary arteries sit dangerously close to the replacement valve. Researchers have now demonstrated a way to prevent coronary blockage and restore blood flow without opening the chest, offering a potential alternative to open-heart surgery.

Researchers at the National Institutes of Health (NIH, Bethesda, MD, USA), in collaboration with Emory School of Medicine (Atlanta, GA, USA), have developed a novel catheter-based procedure specifically for patients at high risk of coronary obstruction during valve replacement. The approach builds on transcatheter access through blood vessels in the leg but introduces entirely new navigation and re-entry steps inside the heart.

The technique, called ventriculo-coronary transcatheter outward navigation and re-entry (VECTOR), creates a new pathway for coronary blood flow at a safe distance from the heart valve. Using guidewires and catheters, clinicians redirect blood from the aorta into the coronary circulation without cutting through the chest wall. This strategy effectively relocates the coronary artery opening away from the danger zone created by valve implantation.

The procedure was performed in a 67-year-old man with a failing bioprosthetic aortic valve whose anatomy made both open-heart surgery and existing minimally invasive options unviable. Through VECTOR, the team created a new coronary bypass route using internal vascular access and deployed a graft to restore safe blood flow. Six months after the intervention, the patient showed no signs of coronary artery obstruction or related complications. The findings demonstrate the feasibility of this approach in humans.

In addition to preventing valve-related coronary obstruction, the technique may have broader applications in treating complex coronary artery disease when stents or standard bypass methods are not suitable. While the initial result is encouraging, additional procedures in more patients will be required before the method can be adopted more widely. Future studies will focus on safety, reproducibility, and long-term outcomes.

“Achieving this required some out-of-the-box thinking but I believe we developed a highly practical solution,” said Christopher Bruce, MBChB, first author of the study.

Related Links:
NIH 
Emory School of Medicine


Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Neonatal Ventilator Simulation Device
Disposable Infant Test Lung
Ureteral Dilatation Balloon
Dornier Equinox
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.